#United States #Palo Alto #Hypertension #renal denervation #Recor Medical

Innovations in Hypertension Treatment

As we observe World Hypertension Day on May 17, 2025, the spotlight is on the alarming increase in hypertension rates and the innovations driving this field forward. Dubbed the “silent killer,” high blood pressure affects millions of people worldwide, often without their awareness. This year's theme, "Measure Your Blood Pressure Accurately, Control It, Live Longer!", truly captures the urgency of addressing this common yet dangerous condition.

The Scale of Hypertension

According to recent reports from the World Health Organization, the adults diagnosed with hypertension have doubled from 1990 to 2019, soaring from 650 million to approximately 1.3 billion. Alarmingly, only 54% of adults with hypertension have been diagnosed, and a mere 42% are receiving adequate treatment. Furthermore, studies indicate that clinical assessments frequently misdiagnose hypertension, putting patients at grave risk for heart attacks, strokes, and kidney diseases if left untreated.

The Challenge of Resistant Hypertension

Despite lifestyle changes and the use of multiple medications, about one-third of patients with hypertension remain unable to control their blood pressure effectively. This unfortunate reality highlights the need for groundbreaking advancements in treatment options. Patients require solutions that promise tangible health improvements; thus, innovation in both medications and medical devices is crucial.

The Paradise™ Ultrasound Renal Denervation (uRDN) system by Recor Medical offers a ray of hope for those battling resistant hypertension. This innovative system aims to lower blood pressure through a unique approach, targeting the sympathetic nerves surrounding renal arteries that contribute to elevated blood pressure.

The Paradise System in Focus

The Paradise uRDN technology employs ultrasound energy to denervate these nerves, with the procedure administered via a catheter that delivers targeted ultrasound doses lasting just seven seconds each. This method boasts a HydroCooling™ system, which circulates sterile water to protect surrounding tissues during the procedure, thus enhancing safety.

Prof. Andrew Sharp from University College Dublin asserts the importance of taking a risk-based approach to hypertension. He emphasizes that even slight reductions in blood pressure can significantly decrease the risks associated with cardiovascular complications. New guidelines suggest lower blood pressure targets than previously recommended, increasing the demand for innovative therapies like the Paradise system.

The reliability of renal denervation has gained credibility within the medical community, receiving backing from major medical societies including the American Heart Association and the European Society of Cardiology. Early intervention in hypertension can stave off vascular aging and minimize complications, yet over half of the hypertensive population still fails to meet basic control standards.

Research and Development

Recor Medical has focused on developing this technology since 2009, undergoing numerous clinical trials to establish the safety and effectiveness of the Paradise System. Currently, they are gathering real-world data through the US Global Paradise System (GPS) Post-Approval Study, which includes long-term follow-ups for patients with uncontrolled hypertension.

As an adjunct treatment for those who have not had success with lifestyle modifications and conventional medications, the Paradise uRDN system offers a new pathway toward achieving blood pressure control safely and effectively, usually within an hour and with an excellent safety profile.

Final Words

As World Hypertension Day reminds us, awareness and proactive management of blood pressure are vital. The emergence of innovative solutions like the Paradise uRDN system signifies a hopeful shift for millions struggling with hypertension. The time for change is now, and with it, we can work toward a healthier tomorrow for all those affected by high blood pressure.